With a revenue increase of 32.4% in the second quarter 2026, year on year to cumulative value of $830 million, Supernus Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,273,678, this marks a new company high.
Within the Healthcare sector Employees of 68 other companies have achieved higher revenue per employee. While Supernus Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 508 to 745. Supernus Pharmaceuticals Inc has 652 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SUPN Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	32.4 %	38.63 %	21.48 %	9.34 %	-1.71 %
Sales per Employee (TTM) $	1,273,678	1,191,462	1,102,687	1,045,305	1,020,130
SUPN's Total Ranking	# 745	# 508	# 665	# 455	# 674
Seq. Revenue Change	5.47 %	-1.83 %	10.13 %	16.11 %	10.43 %

SUPN Company Profile >> Back to SUPN Efficiency Comparisons >> Compare SUPN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 46
Healthcare Sector	# 69
Overall Market	# 745

Revenue per Employee Statistics
High	Average	Low
$ 1,273,678	$ 609,292	$ 2,176
(Jun 30 2026)		(Mar 31 2013)

Financial Statements
Supernus Pharmaceuticals Inc 's Revenue MRQ	$ 219 Millions	Visit SUPN's Income Statement
Supernus Pharmaceuticals Inc 's Revenues TTM	$ 830 Millions	Visit SUPN's aggregate revenue growth
What are SUPN's Sales?		Visit SUPN's Sales by Segment

Other Ratios
Supernus Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SUPN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SUPN's Competitors
Revenue per Employee for SUPN's Suppliers
Revenue per Employee for SUPN's Customers

You may also want to know
SUPN's Sales Growth Rates	SUPN's Pe Price to earnings ratio	SUPN's Receivables Turnover Ratio	SUPN's Stock Quote
SUPN's Net Income Growth Rates	SUPN's Ps Price to Sales ratio	SUPN's Sales per Employee	SUPN's Asset Turnover Ratio
SUPN's Net Margin	SUPN's Pb Price to Book ratio	SUPN's Financial Strength Ratios	SUPN's Dividend Payout Ratio

Date modified: 2026-09-13T23:36:29+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Biocryst Pharmaceuticals Inc	2,162,328.74	$ 940.613 Million	435
Elite Pharmaceuticals Inc	2,155,839.86	$ 140.130 Million	65
Protagonist Therapeutics inc	2,136,303.03	$ 281.992 Million	132
Exelixis Inc	2,123,731.47	$ 2,435.920 Million	1,147
Zevra Therapeutics Inc	2,112,377.05	$ 128.855 Million	61
Liquidia Corporation	2,087,532.41	$ 450.907 Million	216
Tg Therapeutics Inc	2,003,849.62	$ 799.536 Million	399
Prestige Consumer Healthcare Inc	1,938,521.05	$ 1,104.957 Million	570
Privia Health Group Inc	1,923,384.18	$ 2,358.069 Million	1,226
Alnylam Pharmaceuticals Inc	1,921,672.80	$ 4,804.182 Million	2,500
Gilead Sciences Inc	1,791,588.24	$ 30,457.000 Million	17,000
Collegium Pharmaceutical Inc	1,777,172.58	$ 751.744 Million	423
Fennec Pharmaceuticals Inc	1,692,028.57	$ 59.221 Million	35
Neurocrine Biosciences Inc	1,686,950.00	$ 3,373.900 Million	2,000
Mirum Pharmaceuticals Inc	1,661,470.43	$ 618.067 Million	372
Tarsus Pharmaceuticals Inc	1,638,732.43	$ 606.331 Million	370
Agenus Inc	1,638,185.19	$ 132.693 Million	81
Xenetic Biosciences Inc	1,630,388.50	$ 3.261 Million	2
Ideaya Biosciences Inc	1,614,668.97	$ 234.127 Million	145
Eli Lilly And Company	1,593,316.00	$ 79,665.800 Million	50,000
Jazz Pharmaceuticals Plc	1,592,122.15	$ 4,601.233 Million	2,890
Rigel Pharmaceuticals Inc	1,590,718.39	$ 276.785 Million	174
Progyny Inc	1,531,890.19	$ 1,311.298 Million	856
Bristol myers Squibb Company	1,513,415.38	$ 49,186.000 Million	32,500
Krystal Biotech Inc	1,493,166.10	$ 440.484 Million	295
Acadia Pharmaceuticals Inc	1,426,870.93	$ 1,138.643 Million	798
Madrigal Pharmaceuticals Inc	1,403,213.11	$ 1,283.940 Million	915
Indivior Pharmaceuticals Inc	1,333,000.00	$ 1,333.000 Million	1,000
Arcutis Biotherapeutics Inc	1,310,680.79	$ 463.981 Million	354
Lantheus Holdings Inc	1,303,724.22	$ 1,555.343 Million	1,193

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.